Hospital de Base de Sao Jose do Rio Preto
Sao Jose Do Rio Preto, SP, Brazil
Hospital in São José do Rio Preto, State of São Paulo
Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000
About Hospital de Base de Sao Jose do Rio Preto
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
15
Janssen Research & Development, LLC
12
Boehringer Ingelheim
5
Eli Lilly and Company
4
Amgen
3
Bayer
3
Janssen Vaccines & Prevention B.V.
3
Merck Sharp & Dohme LLC
3
AstraZeneca
2
Daiichi Sankyo, Inc.
2
Hospital Israelita Albert Einstein
2
Clinical Trials at Hospital de Base de Sao Jose do Rio Preto
During the past decade, Hospital de Base de Sao Jose do Rio Preto conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 25 clinical trials were completed, i.e. on
average, 36.2% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 18 clinical trials were completed. i.e. 52.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
2009-05-01
2015-12-01
Completed
115
Acute Kidney Injury After Cardiac Surgery Based on KDIGO Criteria
2003-01-01
2013-06-01
Completed
2,804
Immunotherapy With Racotumomab in Advanced Lung Cancer
2010-09-01
2016-09-01
Unknown status
1,082
Management of Myocardial Injury After Noncardiac Surgery Trial
2013-01-01
2018-03-01
Completed
1,754
A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488
2013-01-15
2016-06-06
Completed
26
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
2013-03-29
2019-12-09
Completed
621
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
2013-08-26
2028-08-29
Active, not recruiting
450
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
2013-09-03
2023-12-29
Active, not recruiting
327
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital de Base de Sao Jose do Rio Preto" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Janssen Research & Development, LLC" with 12 trials
sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Amgen"
with 4 trials sponsored. Other sponsors include 35 different institutions and
companies that sponsored additional 35 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Base de Sao Jose do Rio Preto"
#1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Ministry of Health, Brazil" with 2 trials as a collaborator and "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Hospital de Base de Sao Jose do Rio Preto
According to Clinical.Site data, the most researched conditions in "Hospital de Base de Sao Jose do Rio Preto" are
"Prostatic Neoplasms" (4 trials), "Breast Cancer" (3 trials), "COVID-19" (3 trials), "Metastatic Breast Cancer" (3 trials) and "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Hospital de Base de Sao Jose do Rio Preto" in a lesser frequency.
Clinical Trials Intervention Types at Hospital de Base de Sao Jose do Rio Preto
Most popular intervention types in "Hospital de Base de Sao Jose do Rio Preto" are "Drug" (69 trials), "Biological" (11 trials), "Other" (9 trials), "Device" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (30 trials), "Atezolizumab" (5 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital de Base de Sao Jose do Rio Preto
The vast majority of trials in "Hospital de Base de Sao Jose do Rio Preto" are
71 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Hospital de Base de Sao Jose do Rio Preto
Currently, there are NaN active trials in "Hospital de Base de Sao Jose do Rio Preto".
undefined are not yet recruiting,
22 are recruiting,
26 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Hospital de Base de Sao Jose do Rio Preto,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital de Base de Sao Jose do Rio Preto, 4 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 58 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 3 trials that are defined as “Not Applicable".